|
1
|
Panieri E: Breast cancer screening in
developing countries. Best Pract Res Clin Obstet Gynaecol.
26:283–290. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fan L, Zheng Y, Yu KD, Liu GY, Wu J, Lu
JS, Shen KW, Shen ZZ and Shao ZM: Breast cancer in a transitional
society over 18 years: Trends and present status in Shanghai,
China. Breast Cancer Res Treat. 117:409–416. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim YM, Tsoyi K, Jang HJ, Park EJ, Park
SW, Kim HJ, Hwa JS and Chang KC: CKD712, a synthetic isoquinoline
alkaloid, enhances the anti-cancer effects of paclitaxel in
MDA-MB-231 cells through regulation of PTEN. Life Sci. 112:49–58.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sonnenblick A, Eleyan F, Peretz T, Ospovat
I, Merimsky O, Sella T, Peylan-Ramu N and Katz D: Gemcitabine in
combination with paclitaxel for advanced soft-tissue sarcomas. Mol
Clin Oncol. 3:829–832. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wall ME, Wani MC and Taylor H: Plant
antitumor agents, 27. Isolation, structure, and structure activity
relationships of alkaloids from Fagara macrophylla. J Nat Prod.
50:1095–1099. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Quispe-Soto ET and Calaf GM: Effect of
curcumin and paclitaxel on breast carcinogenesis. Int J Oncol.
49:2569–2577. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wen G, Qu XX, Wang D, Chen XX, Tian XC,
Gao F and Zhou XL: Recent advances in design, synthesis and
bioactivity of paclitaxel-mimics. Fitoterapia. 110:26–37. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bharadwaj R and Yu H: The spindle
checkpoint, aneuploidy, and cancer. Oncogene. 23:2016–2027. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Brito DA, Yang Z and Rieder CL:
Microtubules do not promote mitotic slippage when the spindle
assembly checkpoint cannot be satisfied. J Cell Biol. 182:623–629.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li LX, Ye SL, Wang YH and Tang ZZ:
Progress on experimental research and clinical application of
Trametes robiniophila. Bull Chin Cancer. 16:110–113.
2007.
|
|
12
|
Guo YW, Cheng PW, Chen YJ, et al: Studies
on the constituents of polysaccharide from the hyphae of
Trametes robiniophila (II) - identification of
polysaccharide from the hyphae of Trametes robiniophila and
determination of its molar ratio. J Chin Pharm U. 23:155–157.
1992.
|
|
13
|
Guo Y, Cheng P and Chen Y: Isolation and
analysis of the polysaccharide of Huaier mycelium. Chin J Biochem
Pharm. 63:56–59. 1993.
|
|
14
|
Zhang N, Kong X, Yan S, Yuan C and Yang Q:
Huaier aqueous extract inhibits proliferation of breast cancer
cells by inducing apoptosis. Cancer Sci. 101:2375–2383. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huo Q and Yang QF: Role of Huaier extract
as promising anticancer drug. Adaptive Med. 4:2076–944X. 2012.
|
|
16
|
Zhang T, Wang K, Zhang J, Wang X, Chen Z,
Ni C, Qiu F and Huang J: Huaier aqueous extract inhibits colorectal
cancer stem cell growth partially via downregulation of the
Wnt/β-catenin pathway. Oncol Lett. 5:1171–1176. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zheng J, Li C, Wu X, Liu M, Sun X, Yang Y,
Hao M, Sheng S, Sun Y, Zhang H, et al: Astrocyte elevated gene-1
(AEG-1) shRNA sensitizes Huaier polysaccharide (HP)-induced
anti-metastatic potency via inactivating downstream P13K/Akt
pathway as well as augmenting cell-mediated immune response. Tumour
Biol. 35:4219–4224. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bao H, Liu P, Jiang K, Zhang X, Xie L,
Wang Z and Gong P: Huaier polysaccharide induces apoptosis in
hepatocellular carcinoma cells through p38 MAPK. Oncol Lett.
12:1058–1066. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xie HX, Xu ZY, Tang JN, Du YA, Huang L, Yu
PF and Cheng XD: Effect of Huaier on the proliferation and
apoptosis of human gastric cancer cells through modulation of the
PI3K/AKT signaling pathway. Exp Ther Med. 10:1212–1218. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang X, Zhang N, Huo Q, Sun M, Lv S and
Yang Q: Huaier aqueous extract suppresses human breast cancer cell
proliferation through inhibition of estrogen receptor α signaling.
Int J Oncol. 43:321–328. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Qi W, Sun M, Kong X, Li Y, Wang X, Lv S,
Ding X, Gao S, Cun J, Cai C, et al: Huaier extract synergizes with
tamoxifen to induce autophagy and apoptosis in ER-positive breast
cancer cells. Oncotarget. 7:26003–26015. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sen R and Baltimore D: Multiple nuclear
factors interact with the immunoglobulin enhancer sequences. Cell.
46:705–716. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li F, Zhang J, Arfuso F, Chinnathambi A,
Zayed ME, Alharbi SA, Kumar AP, Ahn KS and Sethi G: NF-κB in cancer
therapy. Arch Toxicol. 89:711–731. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang W, Nag SA and Zhang R: Targeting the
NFκB signaling pathways for breast cancer prevention and therapy.
Curr Med Chem. 22:264–289. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhao N, Wang R, Zhou L, Zhu Y, Gong J and
Zhuang SM: MicroRNA-26b suppresses the NF-κB signaling and enhances
the chemosensitivity of hepatocellular carcinoma cells by targeting
TAK1 and TAB3. Mol Cancer. 13:352014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pommier Y, Sordet O, Antony S, Hayward RL
and Kohn KW: Apoptosis defects and chemotherapy resistance:
Molecular interaction maps and networks. Oncogene. 23:2934–2949.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li F and Sethi G: Targeting transcription
factor NF-kappaB to overcome chemoresistance and radioresistance in
cancer therapy. Biochim Biophys Acta. 1805:167–180. 2010.PubMed/NCBI
|
|
28
|
Fan L, Strasser-Weippl K, Li JJ, St Louis
J, Finkelstein DM, Yu KD, Chen WQ, Shao ZM and Goss PE: Breast
cancer in China. Lancet Oncol. 15:e279–e289. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ji D and Mai D: Effect of Huaier Granule
on immunity and quality of life in patient with gastric cancer
undergoing postoperative concurrent radiochemotherapy. China
Cancer. 19:73–76. 2010.
|
|
30
|
Song X, Li Y, Zhang H and Yang Q: The
anticancer effect of Huaier (Review). Oncol Rep. 34:12–21. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jeong YJ, Kang JS, Lee SI, So DM, Yun J,
Baek JY, Kim SK, Lee K and Park SK: Breast cancer cells evade
paclitaxel-induced cell death by developing resistance to
dasatinib. Oncol Lett. 12:2153–2158. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
McGrogan BT, Gilmartin B, Carney DN and
McCann A: Taxanes, microtubules and chemoresistant breast cancer.
Biochim Biophys Acta. 1785:96–132. 2008.PubMed/NCBI
|
|
33
|
Huang Y, Johnson K, Norris J and Fan W:
NF-kB/IkB signaling pathways may contribute to the mediation of
paclitaxel-induced apoptosis in solid tumor cells. Cancer Res.
60:4426–4432. 2000.PubMed/NCBI
|
|
34
|
Bava SV, Sreekanth CN, Thulasidasan AK,
Anto NP, Cheriyan VT, Puliyappadamba VT, Menon SG, Ravichandran SD
and Anto RJ: Akt is upstream and MAPKs are downstream of NF-κB in
paclitaxel-induced survival signaling events, which are
down-regulated by curcumin contributing to their synergism. Int J
Biochem Cell Biol. 43:331–341. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang YB, Zhang GQ, Wang JS and Zhang QF:
Function and clinical application of Huaier plaster in
comprehensive therapy of breast cancer. Chin J Clin Oncol Rehabil.
11:62004.
|
|
36
|
Uetsuka H, Haisa M, Kimura M, Gunduz M,
Kaneda Y, Ohkawa T, Takaoka M, Murata T, Nobuhisa T, Yamatsuji T,
et al: Inhibition of inducible NF-kappaB activity reduces
chemoresistance to 5-fluorouracil in human stomach cancer cell
line. Exp Cell Res. 289:27–35. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Maroun CR and Rowlands T: The Met receptor
tyrosine kinase: A key player in oncogenesis and drug resistance.
Pharmacol Ther. 142:316–338. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Raghav KP, Wang W, Liu S, Chavez-MacGregor
M, Meng X, Hortobagyi GN, Mills GB, Meric-Bernstam F, Blumenschein
GR Jr and Gonzalez-Angulo AM: cMET and phospho-cMET protein levels
in breast cancers and survival outcomes. Clin Cancer Res.
18:2269–2277. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gherardi E, Birchmeier W, Birchmeier C and
Vande Woude G: Targeting MET in cancer: Rationale and progress. Nat
Rev Cancer. 12:89–103. 2012. View
Article : Google Scholar : PubMed/NCBI
|
